Summary The metabolism of cholesterol has been investigated in tumour cells, ascitic fluid and blood serum during the growth of an ascites hepatoma Alterations of cholesterol metabolism have been consistently observed in a variety of experimental tumour models (Coleman & Lavietes, 1981; Van Blitterswijk et al., 1985; Clayman et al., 1986; Erickson et al., 1988) as well as in human neoplasias (Gebhard et al., 1987) . These alterations include an increase in cholesterol content, associated with enhanced rates of de novo cholesterol synthesis and deregulation at the level of hydroxy-methyl-glutarylcoenzyme A reductase (HMGR), the rate limiting enzyme in sterol synthesis. It has been suggested that such changes could be related to an increased requirement of cholesterol for new membrane biogenesis that accompany cell growth (Coleman & Lavietes, 1981) . More recently, however, the possibility that an increased production of mevalonate and its nonsterol isoprenoid products is needed in the initiating phases of DNA replication has been also proposed (Habenicht et al., 1980; Siperstein, 1984) . Similar patterns of intracellular cholesterol metabolism were found in the hepatic hyperplasia induced by a potent mitogen, lead nitrate (Dessi et al., 1984) , and in regenerating liver after partial surgical hepatectomy (Dessi et al., 1986) . These similarities indicate that the above changes in cholesterol metabolism are related to cell proliferation per se, rather than to tumour growth in particular. Hepatic hyperplasia was characterised by peculiar alterations of cholesterol distribution also in the plasma compartment, namely a decrease in HDL cholesterol as well as in the HDL2/HDL3 ratio (Dessi et al., 1986; .
Alterations of cholesterol metabolism have been consistently observed in a variety of experimental tumour models (Coleman & Lavietes, 1981; Van Blitterswijk et al., 1985; Clayman et al., 1986; Erickson et al., 1988) as well as in human neoplasias (Gebhard et al., 1987) . These alterations include an increase in cholesterol content, associated with enhanced rates of de novo cholesterol synthesis and deregulation at the level of hydroxy-methyl-glutarylcoenzyme A reductase (HMGR), the rate limiting enzyme in sterol synthesis. It has been suggested that such changes could be related to an increased requirement of cholesterol for new membrane biogenesis that accompany cell growth (Coleman & Lavietes, 1981) . More recently, however, the possibility that an increased production of mevalonate and its nonsterol isoprenoid products is needed in the initiating phases of DNA replication has been also proposed (Habenicht et al., 1980; Siperstein, 1984) . Similar patterns of intracellular cholesterol metabolism were found in the hepatic hyperplasia induced by a potent mitogen, lead nitrate (Dessi et al., 1984) , and in regenerating liver after partial surgical hepatectomy (Dessi et al., 1986) . These similarities indicate that the above changes in cholesterol metabolism are related to cell proliferation per se, rather than to tumour growth in particular. Hepatic hyperplasia was characterised by peculiar alterations of cholesterol distribution also in the plasma compartment, namely a decrease in HDL cholesterol as well as in the HDL2/HDL3 ratio (Dessi et al., 1986; .
Cholesterol metabolism in the body is regulated through a complex series of transport and biosynthetic mechanisms, which rely on the continuous exchange of cholesterol between tissues and blood. It is thus conceivable that any substantial alteration in the metabolism of cholesterol at the cellular level (e.g. during cell proliferation) may entail changes in the plasmatic pools of cholesterol.
In the present study, cholesterol metabolism was investigated in tumour cells and in the blood compartment in rats during the growth of a highly deviated fast growing ascites hepatoma (Yoshida AH-130).
The study was made at different time intervals after tumour transplantation in order to evaluate the alterations occurring in the malignant cells and whether these were associated with changes in the cholesterol distribution in the plasma of the host animal, as already observed in different models of cell proliferation (Dessi et al., 1986; (Tessitore et al., 1987) . As previously reported (Tessitore et al., 1987) Boer (1975) and protein by the method of Lowry et al. (1951) using sperm DNA and bovine serum albumin as the working standards, respectively.
The presence of tumour necrosis factor (TNF) in the blood plasma was tested on L929 cells according to Flick and Gifford (1984) ; one unit of activity was defined as the reciprocal dilution required to produce a 50% decrease in absorbance relative to control cells exposed to actinomycin alone.
Cholesterol, triglyceride and phospholipid concentrations in serum and ascitic fluid were estimated using reagents obtained commercially (Boehringer, Mannheim, FRG). Very low density lipoproteins (VLDL) and LDL were isolated from serum and ascitic fluid by precipitations with a mixture of phosphotungstic acid and magnesium ions. After standing for 10 min at room temperature, the mixtures were centrifuged at 10,000 g for 10 min, the supernatant containing the HDL fraction was removed and the levels of cholesterol, triglyceride and phospholipid were determined. The precipitate containing VLDL and LDL fractions was dissolved in 0.15 M NaCl and the level of cholesterol, triglyceride and phospholipid was estimated as above. Proteins in VLDL + LDL and HDL subfractions were determined according to. Lowry et al. (1951) .
Apoproteins in VLDL + LDL and in HDL were separated by high-performance liquid chromathography (HPLC). One hundred jil of the VLDL + LDL and HDL fractions were added to 1 ml of 0.1 M sodium phosphate buffer pH 7.0 containing 0.1% sodium dodecyl sulphate (SDS) according to Okazaky et al. (1984) .
The mixed solution was incubated at 60°C for 5 min and then used for HPLC analysis. Standard proteins (SDS molecular weight markers ranging from 14,000 to 70,000 purchased from Sigma) were dissolved in the same buffer and similarly incubated at 60°C for 5 min. Apoproteins of apparent molecular weight <14,000 to 60,000 were resolved on HPLC with aqueous gel permeation column (TSK-GEL, Toyo Soda). HPLC conditions in these experiments were as follows: Column: G 3000 SW (column size, 7.5 mm ID x 600 mm); eluant, 0.1 M sodium phosphate buffer (pH 7.0) containing 0. 1% SDS; flow rate, 0.3 ml min; applied volume, 175 glI). Eluted proteins were detected spectrophotometrically at 280 nm.
Statistical evaluations Statistical comparisons of two means were made with the Student's t-test. Multiple comparisons were computed using one-way analysis of variance.
Results
A slight decrease in body weight was evident in rats 4 days after tumour transplantation, while this change was more marked at 7 and 10 days (Table I) .
DNA and cholesterol synthesis in tumour cells during the growth of Yoshida ascites hepatoma AH-130 are shown in Table II .
The incorporation of 3H-thymidine in tumour cells steadily declined from day 4 to day 10, when the AH-1 30 tumour entered a stationary phase of growth. The maximum incorporation of 3H20 into cholesterol was reached at 7 days after (Table IV) . These changes in liver cholesterol content were associated with a significant decrease of hepatic cholesterol synthesis at day 4 and 7 after tumour transplantation.
The lipid and protein content of whole plasma collected from control and hepatoma-bearing rats is presented in Table   V . While plasma protein slightly decreased, the levels of all lipid classes were elevated in tumour-bearing animals.
In Table VI The plasma concentration of TNF was 9-10 U ml' in tumour bearing rats. No detectable concentration of TNF was observed in plasma of control animals.
Proteins of apparent molecular weight <14,000-60,000 were resolved on HPLC. The apoprotein patterns of VLDL + LDL and HDL lipoprotein fractions are shown for both control and tumour-host serum in Figures 1 and 2 . Three commonly recognised apolipoproteins of rat serum are clearly evident for HDL fraction: Apo A-IV, Apo Al and Apo C, while Apo E and ApoC are evident in VLDL + LDL fraction. In tumour bearing rats, HDL showed a decrease in the protein profile corresponding to Apo A IV and Apo Al at all time points considered, while a consistent increase in Apo E was observed in the VLDL + LDL fraction.
Discussion
Alterations of cholesterol metabolism, including an increase of cholesterol synthesis and an accumulation of cholesterol esters in proliferating tissues associated with a decrease of HDL cholesterol in serum, were previously found in different experimental models of cell proliferation (Dessi et al., 1984; .
The present study confirms and extends these observations using as a model the rat ascites hepatoma AH-130, a rapidly growing lethal tumour.
In this model the increase of cholesterol synthesis was associated with a progressive accumulation of cholesterol in growing AH-130 cells. Initially, the accumulation was mostly due to an increased content in cholesterol esters, and later an increase in free cholesterol was also observed. These findings are consistent with several reports in the literature showing that, in a variety of tumours, cell membranes are enriched in free cholesterol (Feo et al., 1973) and that cholesterol esters accumulate in tumour cells (Clayman et al., 1986; Rao et al., 1983) or in the proliferating tissue (Dessi et al., 1984; Fex & Wallinder, 1973) .
The biological significance of such phenomena remains to be established, nor is it clear whether the cholesterol accumulated in tumour tissues derives from new synthesis and/or increased uptake. However, it is likely that during processes of rapid cell proliferation, cholesterol esters are stored inside cells probably to meet the increased demand of cholesterol for new membrane biogenesis.
Alterations of intracellular cholesterol metabolism were accompanied by changes in total serum lipids and in lipoprotein profiles. All plasma lipid classes were elevated. This was due to an increase of lipid moietes in VLDL + LDL while phospholipid and cholesterol in HDL fractions were actually decreased.
Concomitantly, changes in host apoproteins were also observed: Apo E increased in VLDL + LDL fractions, while a decline in Apo Al and Apo AIV was observed in HDL lipoproteins. The latter observation suggests that changes in lipoprotein pattern in tumour-bearing rats may not be entirely explained by alterations in the amount of lipids bound to each lipoprotein class, but could also be related to changes in the absolute number of circulating lipoprotein particles.
The interpretation of our overall results is complicated because the distribution of lipids in the different classes of lipoproteins reflects the balance of lipids derived from endogenous biosynthesis, catabolism, diet, mobilisation of stored fat and the tumour itself.
In our model, tumour-bearing rats, developed a pronounced hypercholesterolemia and hypertriglyceridemia during the total period of tumour growth. At least a few possibilities can be considered to explain these findings: an increase mobilisation of lipids from fat depots as evidenced by the observed cachexia, a decreased catabolism of VLDL mediated by TNF (Ettinger et al., 1990) , being this vector elevated in serum during tumour growth and finally, since an increase in Apo E was also found, a decreased uptake by the liver of VLDL and LDL via Apo E receptors must be also considered. These three possibilities are not mutually exclusive.
It appears unlikely that changes in diet and endogenous biosynthesis may be involved under our experimental conditions. Hepatic cholesterol synthesis and food intake, the two main sources of plasma lipid under normal conditions, were in fact both decreased in tumour-bearing rats. In this model, HDL steadily decreased over the course of tumour growth (4 and 7 days), then increased to near normal levels at 10 days, a time coinciding with the stationary phase of tumour growth. Thus it seems that the decrease in HDL levels may be a specific response to cell proliferation rather than directly related to the presence of tumour. A decrease of HDL was previously observed in our laboratories in different experimental models of cell proliferation, such as liver regeneration after partial hepatectomy (Dessi et al., 1986) , bone marrow hyperplasia induced by phenylhydrazine and more recently in patients with different types of haematologic neoplasma (Dessi et al., 1991) and in G6PD deficient children with bone marrow hyperplasia after haemolysis induced by ingestion of fava bean (favism) (Dessi et al., 1992) . In these models, however, the decrease of HDL was not associated with hyperlipidemia.
Taken together these findings suggest that the reported changes in total plasma lipid concentrations do not reflect a general pattern associated with growth, being variable and dependent on the type of hyperplastic or neoplastic growth. In contrast, the decrease in HDL fraction, virtually present in all models of cell proliferation, seems to represent a generalised phenomenon related to rapid cell proliferative processes.
A major function attributed to HDL is the ability to remove excess cholesterol from extrahepatic cells (Eisenberg, 1984) . Since during proliferative processes the utilisation and storage of cholesterol are increased in proliferating tissues, it is possible to hypothesise that the observed decrease in HDL may be caused, at least partially, by a reduced release of free cholesterol from proliferating cells to HDL. Many studies in vitro support this conclusion: the exposure to HDL results in a net efflux of free cholesterol from various cultured cells (Daerr et al., 1980; Daniels et al., 1980) , this efflux being partially blocked in rapidly proliferating cells and in transformed cell lines (Gebhard et al., 1987; Pittman et al., 1987) .
Furthermore, Oram et al. (1987) have demonstrated that Apo AI-HDL binds to cell surface receptors and promotes selective removal of excess cholesterol from intracellular pool. The activity of these receptors is regulated by both the availability of exogenous cholesterol and the growth state of the cells.
Treatment of quiescent cells with serum growth factors suppresses both HDL receptor activity and HDL-mediated cholesterol efflux (Bierman et al., 1989 ). An opposite effect was obtained by the treatment of cultured fibroblasts with inhibitors of cell proliferation (Oppenheimer et al., 1988) .
In line with these data, we have recently demonstrated that the inhibition in vivo of cholesterol esters accumulation by a specific inhibitor of ACAT, strongly prevents the decrease of HDL normally found during proliferative processes , giving support to the hypothesis that HDL alterations in serum are dependent on the altered cholesterol metabolism in proliferating tissues.
